Figure 5From: Development of a RVFV ELISA that can distinguish infected from vaccinated animalsComparison of the N and NSs response in various human sera. Antigens were coated onto EIA plates as described in Methods. After overnight binding and then blocking, the plates were incubated with serially diluted human sera, and then with anti-human HRP. Samples 1 and 2 are from naturally infected humans. Sample 3 is from a human that was vaccinated with inactivated WT RVFV, and sample N is a negative control human sera. Figure A demonstrates the dilution curves for each sample. Figure B demonstrates the endpoint titers for each antigen for the positive samples.Back to article page